Gaps in patient healthcare, ranging from access and affordability, to those specific to race, gender, age and beyond, are widening across the US and leading to a variety of detrimental results for people, the healthcare system, and the economy itself. Such ongoing disparities are slowing the country’s ability to achieve population health and accounting for billions of dollars in unnecessary health care spending annually.
New breakthroughs in drug development are leading to groundbreaking results that could change lives in 2022 and beyond. However, at the dawn of a new decade, there are major challenges facing the industry that could prevent this innovation revolution. With the rising costs and increasing complexities involved in bringing products to market, life sciences organizations are re-examining their business operations and technology adoption.